VIMOVO

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Aktiivinen ainesosa:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Saatavilla:

ASTRA ZENECA ISRAEL LTD

ATC-koodi:

G02CC02

Lääkemuoto:

TABLETS MODIFIED RELEASE

Antoreitti:

PER OS

Valmistaja:

ASTRA ZENECA AB., SWEDEN

Terapeuttinen ryhmä:

NAPROXEN

Käyttöaiheet:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Valtuutus päivämäärä:

2011-12-01